Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001819790-25-000011
Filing Date
2025-02-25
Accepted
2025-02-25 16:03:56
Documents
178
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tars-20241231.htm   iXBRL 10-K 2389260
2 EX-10.24 tarsuspharmaceuticalsinc.htm EX-10.24 7126
3 EX-10.25 tarsusnewleaseredacted.htm EX-10.25 5164
4 EX-10.26 yeuelizabeth-offerletter.htm EX-10.26 13992
5 EX-10.27 tp-03xnovationandtermina.htm EX-10.27 22476
6 EX-19.1 tarsus-xxinsiderxtrading.htm EX-19.1 63732
7 EX-23.1 exhibit231202410k.htm EX-23.1 4931
8 EX-31.1 exhibit311202410k.htm EX-31.1 9273
9 EX-31.2 exhibit312202410k.htm EX-31.2 9928
10 EX-32.1 exhibit321202410k.htm EX-32.1 9226
11 EX-32.2 exhibit322202410k.htm EX-32.2 9181
17 tars-20241231_g1.jpg GRAPHIC 21438
18 tars-20241231_g2.jpg GRAPHIC 99887
19 tars-20241231_g3.jpg GRAPHIC 98981
20 tars-20241231_g4.jpg GRAPHIC 301525
21 tars-20241231_g5.jpg GRAPHIC 25209
22 tars-20241231_g6.jpg GRAPHIC 51263
23 tars-20241231_g7.jpg GRAPHIC 229333
24 tars-20241231_g8.jpg GRAPHIC 48652
25 tarsus-xxinsiderxtrading001.jpg GRAPHIC 36775
26 tarsus-xxinsiderxtrading002.jpg GRAPHIC 209808
27 tarsus-xxinsiderxtrading003.jpg GRAPHIC 90747
28 tarsus-xxinsiderxtrading004.jpg GRAPHIC 204015
29 tarsus-xxinsiderxtrading005.jpg GRAPHIC 198349
30 tarsus-xxinsiderxtrading006.jpg GRAPHIC 99902
31 tarsus-xxinsiderxtrading007.jpg GRAPHIC 252922
32 tarsus-xxinsiderxtrading008.jpg GRAPHIC 219056
33 tarsus-xxinsiderxtrading009.jpg GRAPHIC 152426
34 tarsus-xxinsiderxtrading010.jpg GRAPHIC 248120
35 tarsus-xxinsiderxtrading011.jpg GRAPHIC 88843
36 tarsus-xxinsiderxtrading012.jpg GRAPHIC 245053
37 tarsus-xxinsiderxtrading013.jpg GRAPHIC 90167
38 tarsus-xxinsiderxtrading014.jpg GRAPHIC 179514
39 tarsus-xxinsiderxtrading015.jpg GRAPHIC 254849
40 tarsus-xxinsiderxtrading016.jpg GRAPHIC 153383
41 tarsus-xxinsiderxtrading017.jpg GRAPHIC 274722
42 tarsus-xxinsiderxtrading018.jpg GRAPHIC 276358
43 tarsus-xxinsiderxtrading019.jpg GRAPHIC 61702
44 tarsus-xxinsiderxtrading020.jpg GRAPHIC 171172
45 tarsus-xxinsiderxtrading021.jpg GRAPHIC 100140
46 tarsus-xxinsiderxtrading022.jpg GRAPHIC 44849
47 tarsus-xxinsiderxtrading023.jpg GRAPHIC 46379
48 tarsus-xxinsiderxtrading024.jpg GRAPHIC 40304
49 tarsus-xxinsiderxtrading025.jpg GRAPHIC 204744
50 tarsus-xxinsiderxtrading026.jpg GRAPHIC 235782
51 tarsus-xxinsiderxtrading027.jpg GRAPHIC 67562
52 tarsusnewleaseredacted001.jpg GRAPHIC 47964
53 tarsusnewleaseredacted002.jpg GRAPHIC 204149
54 tarsusnewleaseredacted003.jpg GRAPHIC 77823
55 tarsusnewleaseredacted004.jpg GRAPHIC 341373
56 tarsusnewleaseredacted005.jpg GRAPHIC 380990
57 tarsusnewleaseredacted006.jpg GRAPHIC 384349
58 tarsusnewleaseredacted007.jpg GRAPHIC 402857
59 tarsusnewleaseredacted008.jpg GRAPHIC 362536
60 tarsusnewleaseredacted009.jpg GRAPHIC 380395
61 tarsusnewleaseredacted010.jpg GRAPHIC 384085
62 tarsusnewleaseredacted011.jpg GRAPHIC 337377
63 tarsusnewleaseredacted012.jpg GRAPHIC 321609
64 tarsusnewleaseredacted013.jpg GRAPHIC 367861
65 tarsusnewleaseredacted014.jpg GRAPHIC 284694
66 tarsusnewleaseredacted015.jpg GRAPHIC 280221
67 tarsusnewleaseredacted016.jpg GRAPHIC 62846
68 tarsuspharmaceuticalsinc001.jpg GRAPHIC 229502
69 tarsuspharmaceuticalsinc002.jpg GRAPHIC 61338
70 tp-03xnovationandtermina001.jpg GRAPHIC 260415
71 tp-03xnovationandtermina002.jpg GRAPHIC 191468
72 tp-03xnovationandtermina003.jpg GRAPHIC 215994
73 tp-03xnovationandtermina004.jpg GRAPHIC 153733
74 tp-03xnovationandtermina005.jpg GRAPHIC 268164
75 tp-03xnovationandtermina006.jpg GRAPHIC 68234
76 tp-03xnovationandtermina007.jpg GRAPHIC 58633
77 tp-03xnovationandtermina008.jpg GRAPHIC 61471
78 tp-03xnovationandtermina009.jpg GRAPHIC 44768
79 tp-03xnovationandtermina010.jpg GRAPHIC 28734
80 tp-03xnovationandtermina011.jpg GRAPHIC 27977
81 tp-03xnovationandtermina012.jpg GRAPHIC 28652
82 tp-03xnovationandtermina013.jpg GRAPHIC 27319
83 tp-03xnovationandtermina014.jpg GRAPHIC 28551
84 tp-03xnovationandtermina015.jpg GRAPHIC 30122
85 tp-03xnovationandtermina016.jpg GRAPHIC 28467
86 tp-03xnovationandtermina017.jpg GRAPHIC 27323
87 tp-03xnovationandtermina018.jpg GRAPHIC 26550
88 yeuelizabeth-offerletter001.jpg GRAPHIC 234790
89 yeuelizabeth-offerletter002.jpg GRAPHIC 279937
90 yeuelizabeth-offerletter003.jpg GRAPHIC 250313
91 yeuelizabeth-offerletter004.jpg GRAPHIC 193892
92 yeuelizabeth-offerletter005.jpg GRAPHIC 41157
  Complete submission text file 0001819790-25-000011.txt   29353092

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tars-20241231.xsd EX-101.SCH 61838
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tars-20241231_cal.xml EX-101.CAL 108291
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tars-20241231_def.xml EX-101.DEF 331924
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tars-20241231_lab.xml EX-101.LAB 852916
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tars-20241231_pre.xml EX-101.PRE 604211
181 EXTRACTED XBRL INSTANCE DOCUMENT tars-20241231_htm.xml XML 1441448
Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39614 | Film No.: 25662938
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)